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Dear Professor Lotti, 
 
We read with interest the review by Queirós and colleagues1 on the wide range of 
uses of photodynamic therapy (PDT) in dermatology. The authors appear to have 
overlooked the use of laser-assisted drug delivery and microneedling for enhancing 
penetration of photosensitising agents during PDT.2 The treatment of actinic 
keratoses with ablative fractional laser technologies (AFXL) prior to PDT allows for 
greater penetration and hence efficacy of treatments with photosensitisers including 
methyl aminolevulinate (MAL) and aminolevulinic acid.3 Combinations of 
microneedling, photodynamic therapy and MAL was used effectively in the treatment 
of recalcitrant actinic keratosis.4 Erbium-doped yttrium aluminium garnet AFXL 
undertaken before MAL-PDT was more efficacious for the treatment of Bowen’s 
disease than a MAL-PDT alone.5 In addition, AFXL pre-treatment prior to PDT in the 
treatment of basal cell carcinomas is thought to create channels to allow greater 
penetration of the active photosensitising agent.2 The potential utility of AFXL-
assisted PDT in patients with actinic cheilitis has been highlighted in a large cohort of 
patients.6 Practitioners undertaking PDT should consider the addition of pre-
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treatment interventions such as AFXL and microneedling to enhance the delivery of 
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